Global Study Maps Pain Across 6.1 Million Individuals Pain prevalence peaks before age 55 for several common anatomical sites, while musculoskeletal back and joint pain continue rising into old age, according to a sweeping global analysis published in Nature Medicine. The study examined self-reported pain data from 6,125,459 participants across 902 population-based data sources in … Read more
Highlight Therapeutics announced positive Phase 2b results for its investigational intralesional basal cell carcinoma treatment, BO-112, at the European Academy of Dermatology and Venereology Congress in Vienna. The study met its primary endpoint of visual and pathological response at week 24 in patients with resectable primary low- and high-risk forms of the disease. Phase 2b … Read more
Clinical data presented at the 2026 American Society for Radiation Oncology Annual Meeting in Boston shows that weekly cisplatin combined with radiation fails to reduce acute toxicity compared with a standard every-three-week dosing schedule for patients with p16-negative locally advanced head and neck cancer. Researchers evaluated 234 eligible patients in the Phase II portion of … Read more
Internal head and neck lymphedema—a fluid accumulation in the oral cavity, pharynx, or larynx caused by cancer treatment damage—affects 74% to 96% of patients. According to a cross-sectional observational study published in the European Journal of Cancer Care on July 14, 2026, by Karin Sjögren’s team at Lund University, Swedish rehabilitation professionals lack consistent assessment … Read more
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new clinical trial findings and research at the American Society for Radiation Oncology (ASTRO) Annual Meeting, detailing advances in personalized radiation therapy, genetic risk testing, and targeted radioligand treatments for prostate, bile duct, and head and neck cancers. According to UCLA Health, … Read more
Immunosuppressed patients diagnosed with non-melanoma skin cancer are not lacking vital cancer-fighting immune cells as previously believed, but rather possess macrophages that have lost their ability to communicate effectively, according to a study published in Cell by researchers at The University of Texas MD Anderson Cancer Center. The findings reveal that macrophages in patients with … Read more
Insilico Medicine published a collaborative study in the journal npj Precision Oncology, detailing how artificial intelligence and multi-omic analysis identified therapeutic targets in inverted papilloma-associated sinonasal squamous cell carcinoma (IP-SNSCC), a rare head and neck cancer. Conducted with researchers from the University of Chicago and Johns Hopkins University, the peer-reviewed paper offers the first comprehensive … Read more
Breakthrough in Oral Cancer Research: New Immune Pathway Could Revolutionize Early Intervention Researchers at The University of Texas MD Anderson Cancer Center have uncovered a critical immune pathway linked to the progression of oral precancerous lesions into head and neck squamous cell carcinoma, offering a potential roadmap for early intervention. The findings, published in *Cancer … Read more
Researchers at Guangzhou University of Chinese Medicine have identified the hypoglossal nucleus (12N) as the primary brainstem motor node responsible for the swallowing improvements observed after electroacupuncture at the “Lianquan” (CV23) acupoint. Published in Acupuncture Research on August 25, 2025 (DOI: 10.13702/j.1000-0607.20250444), the study confirms that this neural pathway is essential for restoring swallowing function … Read more
Obesity and Cancer Risk: How a Landmark Study Rewrote the Rules A new meta-analysis of 1.5 million cancer cases reveals that excess body weight may increase the risk of 19 types of cancer—far more than previously thought. The findings, published in Nature Metabolism, also expose stark regional and gender disparities, challenging global health policies and … Read more